跳至主要内容
临床试验/IRCT201608071556N93
IRCT201608071556N93已完成未知

Efficacy of oral ketamine in treatment of patients with Major depressive disorder: A double – blind controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • age between 18 –60 years old; moderate to severe major depressive disorder based on Diagnostic & Statistical Mental Disorders (DSM-5); HRSD score above20; signing informed consent. Exclusion criteria: receiving antidepressant drugs within the last month; cardiovascular disease; pregnancy and lactation; receiving ECT (Electroconvulsive Therapy) during the last two months; thyroid disease; alcohol & drug abuse.

排除标准

  • 未提供

研究者

相似试验